Topical Oxygen Therapy Awarded Positive Treatment Recommendation by the International Working Group on the Diabetic Foot in their 2023 Diabetic Foot Ulcer Guidelines
AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news from the 9th International Symposium on the Diabetic Foot (ISDF). The IWGDF has recognized the efficacy of topical oxygen therapy in their 2023 Diabetic Foot Ulcer Guidelines, further endorsing AOTI Inc.’s innovative treatment approach.
Topical Oxygen Therapy Awarded “A” Grade Treatment Recommendation by the American Diabetes Association in their 2023 Standards of Care in Diabetes
OCEANSIDE, Calif., Dec. 13, 2022 /PRNewswire/ — Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that the American Diabetes Association has awarded an “A” grade...
AOTI Receives China FDA Approval for Topical Wound Oxygen (TWO2) Therapy Providing Renewed Hope for World’s Largest Diabetic Foot Ulcer Population
OCEANSIDE, Calif., March 23, 2022 /PRNewswire/ — Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that is has received Chinese National Medical Products Administration (NMPA), commonly...